As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A carries a market capitalization of 9.76B, placing it among publicly traded companies globally. Its enterprise value stands at 8.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.76B |
| Enterprise Value | 8.54B |
As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A has 3.00B shares outstanding.
| Shares Outstanding | 3.00B |
These figures are as of September 30, 2026.
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.33 |
As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A maintains a current ratio of 4.98, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.98 |
| Quick Ratio | 1.51 |
| Debt / Equity | 4.01 |
These figures cover the twelve months ended September 30, 2026.
| Employee Count | 4,852.00 |
Over the twelve months ended September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A recorded 30.60M in income tax expense.
| Income Tax | 30.60M |
As of the close on November 17, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A's stock has declined approximately 23.02% over the past 52 weeks. The 50-day moving average sits at 3.21, while the 200-day moving average is 3.36.
| 52-Week Price Change | -23.02% |
| 50-Day Moving Average | 3.21 |
| 200-Day Moving Average | 3.36 |
As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A holds 1.70B in cash and equivalents against 348.17M in total debt, resulting in a net debt position of -1.53B. Total book value stands at 8.57B, with working capital of 4.47B providing operational flexibility.
| Cash & Cash Equivalents | 1.70B |
| Total Debt | 348.17M |
| Net Debt | -1.53B |
| Equity (Book Value) | 8.57B |
| Book Value Per Share | 2.85 |
| Working Capital | 4.47B |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -75.50M |
Over the twelve months ended September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A paid dividends of 0.01 per share.
| Dividend Per Share | 0.01 |
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A's most recent stock split took place on October 26, 2016 with a 1:3 split ratio.
| Last Split Date | 10/26/2016 |
| Split Ratio | 1:3 |
Already premium?